Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Farach

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 2, 2021
Postmastectomy radiation therapy following pathologic complete nodal response to neoadjuvant chemotherapy: A prelude to NSABP B-51?Waqar Haque, Anukriti Singh, Vivek Verma, et al.
International Journal of Radiation Oncology, Biology, Physics|October 20, 2012
Hypopharyngeal dose is associated with severe late toxicity in locally advanced head-and-neck cancer: an RTOG analysisMitchell Machtay, Jennifer Moughan, Andrew Farach, et al.
Clinical Breast Cancer|September 11, 2017
Treatment Outcomes and Prognostic Factors in Male Patients With Stage IV Breast Cancer: A Population-based StudyWei Chen, Ying Huang, Gary D Lewis, et al.
Cancer Communications (London, England)|October 23, 2019
Prognosis of lymphotropic invasive micropapillary breast carcinoma analyzed by using data from the National Cancer DatabaseGary D Lewis, Yan Xing, Waqar Haque, et al.
Future Oncology (London, England)|June 15, 2022
A phase II clinical trial of neoadjuvant sasanlimab and stereotactic body radiation therapy as an <i>in situ</i> vaccine for cisplatin-ineligible MIBC: the RAD VACCINE MIBC trialRaj Satkunasivam, Kelvin Lim, Bin S Teh, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 2, 2025
Outcomes of Radiation Overlap and Margin Length in Intracoronary Brachytherapy for In-Stent RestenosisChloe Kharsa, Devin Olek, Gal Sella, et al.
JACC. Advances|June 11, 2026
Impact of IVUS Guidance on Clinical and Procedural Outcomes in Intracoronary BrachytherapyChloe Kharsa, Gal Sella, Devin Olek, et al.
The Breast Journal|July 20, 2019
The impact of molecular status on survival outcomes for invasive micropapillary carcinoma of the breastGary D Lewis, Yan Xing, Waqar Haque, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|November 21, 2025
Intravascular Brachytherapy for In-Stent Restenosis in Patients With Chronic Kidney DiseaseGal Sella, Chloe Kharsa, Mangesh Kritya, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|June 28, 2025
Outcomes of intravascular brachytherapy for in-stent restenosis in small versus large coronary vesselsGal Sella, Chloe Kharsa, Mangesh Kritya, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 2, 2021
Postmastectomy radiation therapy following pathologic complete nodal response to neoadjuvant chemotherapy: A prelude to NSABP B-51?Waqar Haque, Anukriti Singh, Vivek Verma, et al.
International Journal of Radiation Oncology, Biology, Physics|October 20, 2012
Hypopharyngeal dose is associated with severe late toxicity in locally advanced head-and-neck cancer: an RTOG analysisMitchell Machtay, Jennifer Moughan, Andrew Farach, et al.
Clinical Breast Cancer|September 11, 2017
Treatment Outcomes and Prognostic Factors in Male Patients With Stage IV Breast Cancer: A Population-based StudyWei Chen, Ying Huang, Gary D Lewis, et al.
Cancer Communications (London, England)|October 23, 2019
Prognosis of lymphotropic invasive micropapillary breast carcinoma analyzed by using data from the National Cancer DatabaseGary D Lewis, Yan Xing, Waqar Haque, et al.
Future Oncology (London, England)|June 15, 2022
A phase II clinical trial of neoadjuvant sasanlimab and stereotactic body radiation therapy as an <i>in situ</i> vaccine for cisplatin-ineligible MIBC: the RAD VACCINE MIBC trialRaj Satkunasivam, Kelvin Lim, Bin S Teh, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 2, 2025
Outcomes of Radiation Overlap and Margin Length in Intracoronary Brachytherapy for In-Stent RestenosisChloe Kharsa, Devin Olek, Gal Sella, et al.
JACC. Advances|June 11, 2026
Impact of IVUS Guidance on Clinical and Procedural Outcomes in Intracoronary BrachytherapyChloe Kharsa, Gal Sella, Devin Olek, et al.
The Breast Journal|July 20, 2019
The impact of molecular status on survival outcomes for invasive micropapillary carcinoma of the breastGary D Lewis, Yan Xing, Waqar Haque, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|November 21, 2025
Intravascular Brachytherapy for In-Stent Restenosis in Patients With Chronic Kidney DiseaseGal Sella, Chloe Kharsa, Mangesh Kritya, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|June 28, 2025
Outcomes of intravascular brachytherapy for in-stent restenosis in small versus large coronary vesselsGal Sella, Chloe Kharsa, Mangesh Kritya, et al.
Pageof 5